Ace the CPHON Challenge 2026 – Elevate Your Pediatric Oncology Nursing Game!

Warm Antibody Autoimmune Hemolytic Anemia (AIHA) is characterized by the production of antibodies that react at body temperature and lead to the destruction of red blood cells. It is indeed accurate that approximately 50% of warm antibody cases are idiopathic, meaning that no underlying cause can be determined. This presents a significant challenge in management, as the idiopathic nature of the condition often requires supportive care and treatment of the anemia itself rather than targeting an identifiable cause.

The aetiology of these cases can vary widely in other contexts, as they can be secondary to various conditions, such as lymphoproliferative disorders, infections, or autoimmune diseases. However, the prevalence of idiopathic cases as approximately half remains a notable feature of warm antibody AIHA, making the assertion of 50% being idiopathic correct. This understanding is essential for healthcare providers as it influences diagnostic approaches and treatment strategies in pediatric hematology.